EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial

Paul Bangirana, Andrea L Conroy, Robert O Opoka, Margaret Semrud-Clikeman, Jeong H Jang, Claire Apayi, Abel Kakuru, Mary K Muhindo, Michael K Georgieff, Grant M Dorsey, Moses R Kamya, Diane Havlir und 1 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac815 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Paul Bangirana und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Artemisinins, Quinolines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malaria in pregnancy has been associated with worse cognitive outcomes in children, but its association with behavioral outcomes and the effectiveness of malaria chemoprevention on child neurodevelopment are not well characterized.

Methods

To determine if more effective malaria chemoprevention in mothers and their children results in better neurodevelopment, 305 pregnant women were randomly assigned to 3 doses of sulfadoxine-pyrimethamine, 3 doses of dihydroartemisinin-piperaquine (DP), or monthly DP during pregnancy, and their 293 children were assigned to DP every 3 months or monthly DP from 2 to 24 months of age. Cognition, language, and motor function were assessed at 12, 24. and 36 months of age, and attention, memory, behavior, and executive function were assessed at 24 and 36 months of age.

Results

Children of mothers with versus without malaria in pregnancy had worse scores on cognitive, behavioral, and executive function outcomes at 24 months. Clinical malaria in children within the first 12 months was similarly associated with poorer scores in behavior and executive function at 24 months, language at 24 and 36 months, and motor function scores at 36 months. However, more effective malaria chemoprevention in the mothers and children was not associated with better outcomes.

Conclusions

Malaria in pregnancy was associated with worse cognitive, behavioral, and executive function scores in affected children, but more effective malaria chemoprevention measures did not result in better outcomes. Malaria chemoprevention prior to and early in gestation and with even higher efficacy in mothers and children may be required to prevent neurodevelopmental impairment in children. Clinical Trials Registration. NCT02557425.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalariaArtemisininsQuinolinesChildFemalePregnancyHumansPyrimethamineSulfadoxineDrug CombinationsChemoprevention

Stichwörter der Autor:innen

chemopreventiondevelopmentmalariapregnancy

Substanzen

AntimalarialsPyrimethamineSulfadoxineartenimolArtemisininsDrug CombinationsQuinolines

Autor:innen und Institutionen

  • Department of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda.
  • Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, Indianapolis.
  • Department of Pediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda.
  • Department of Pediatrics, University of Minnesota, Minnesota, USA.
  • Underwood International College and Department of Applied Statistics, Yonsei University, Seoul, Korea.
  • Infectious Diseases Research Collaboration, Kampala, Uganda.

ORCID-Profile: Chandy C John

Förderung

  • NICHD NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institutes of Health

Zitieren

APA

Bangirana, P., Conroy, A. L., Opoka, R. O., Semrud-Clikeman, M., Jang, J. H., Apayi, C., Kakuru, A., Muhindo, M. K., Georgieff, M. K., Dorsey, G. M., Kamya, M. R., Havlir, D., & John, C. C. (2023). Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac815

Vancouver

Bangirana P, Conroy AL, Opoka RO, Semrud-Clikeman M, Jang JH, Apayi C, et al. Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac815

BibTeX
@article{Bangirana2023,
  author = {Bangirana, Paul and Conroy, Andrea L and Opoka, Robert O and Semrud-Clikeman, Margaret and Jang, Jeong H and Apayi, Claire and Kakuru, Abel and Muhindo, Mary K and Georgieff, Michael K and Dorsey, Grant M and Kamya, Moses R and Havlir, Diane and John, Chandy C},
  title = {Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac815}
}
Kostenlos starten →